Clinical trial
Non-interventional Study on Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)
NCT03247582 is registered in ClinicalTrials.gov with Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-interventional Study on Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)
- Lead sponsor
- Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 2, 2017
- Completion date
- May 3, 2022
- Enrollment
- 234 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.